Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The purpose of this study was to describe the psychiatric treatment received by a well-defined sample of patients with borderline personality disorder and Axis II comparison subjects over 6 years of prospective follow-up. METHOD: 362 inpatients were interviewed about their treatment histories during their index admission (1992-1995). 290 patients met both Revised Diagnostic Interview for Borderlines and DSM-III-R criteria for borderline personality disorder and 72 met DSM-III-R criteria for at least 1 nonborderline Axis II disorder (and neither criteria set for borderline personality disorder). Over 94% of surviving patients were re-interviewed about their psychiatric treatment histories 2, 4, and 6 years later. RESULTS: Only 33% of borderline patients were hospitalized during the final 2 years of the 6-year follow-up, a substantial decline from the 79% who had prior hospitalizations at baseline. Much the same pattern emerged for day and/or residential treatment (from 55% to 22%). In contrast, about three quarters of borderline patients were still in psychotherapy and taking psychotropic medications after 6 years of follow-up. Additionally, over 70% of borderline patients participating in these outpatient modalities did so for at least 75% of each follow-up period. While rates of intensive psychotherapy declined significantly over time (from 36% to 16%), rates of intensive polypharmacy remained relatively stable over time, with about 40% of borderline patients taking 3 or more concurrent standing medications during each follow-up period, about 20% taking 4 or more, and about 10% taking 5 or more. CONCLUSIONS: The results of this study suggest that the majority of borderline patients continue to use outpatient treatment in a sustained manner through 6 years of follow-up, but only a declining minority use more restrictive and costly forms of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies on individuals with PD diagnoses demonstrated that BPD individuals differ in usage of outpatient, inpatient, and psychopharmacologic treatments when compared to other PD groups [7,8]”
Citations
Cited by
Items 101–200 of 284
Comorbid personality disorder and treatment use in a community sample of youths: a 20‐year follow‐up
Kasen, S., Cohen, P. R., Skodol, A. E., First, M. B., Johnson, J. G., Brook, J. S., & Oldham, J. M. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00842.x · Cited by 39
“It also is worthy of mention that at mean age 33 individuals with PD only were at elevated odds of past year psychotropic drug use, thus corroborating reports of sustained psychotropic drug use in adult PD patients (50).”
ResultKolla, N. J., Links, P. S., McMain, S., Streiner, D. L., Cardish, R. J., & Cook, M. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400306 · Cited by 32
“Our finding that subjects in this study were taking, on average, greater than 2 prescription psychotropic medications corroborates work carried out by other research groups.(3) As outlined in the APA’s guideline, SSRIs are the preferred choice for targeting symptoms of affective dysregulation or impulsive-behavioural…”
ResultReyes-Ortega, M. A., Miranda, E., Fresán, A., Vargas, A. N., Barragán, S. C., Robles, R., & Arango, I. (2019) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.12240 · Cited by 42
Zimmerman, M. A., Balling, C. E., Chelminski, I., & Dalrymple, K. L. (2020) · Psychological Medicine · doi:10.1017/s0033291720000215 · Cited by 39
The Sequence of Recovery in Long-Term Dynamic Psychotherapy
Perry, J. C., & Bond, M. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181c29a0f · Cited by 33
“Other developments are the long-term naturalistic studies of depression and personality disorders (Zanarini et al., 2004a; 2006; Skodol et al. 2005a&b; Perry et al., 2009; Mueller et al., 1999; Perry, 1988), which have examined the multiyear evolution of patients naturalistically undergoing a…”
BackgroundResultInfluentialSilverman, M. H., Frankenburg, F. R., Reich, D. B., Fitzmaurice, G. M., & Zanarini, M. C. (2012) · Journal of Personality Disorders · doi:10.1521/pedi.2012.26.5.804 · Cited by 38
“The reasons for these differences are not clear but may be due to the fact that the HARP study was following participants with primary anxiety disorders (Yonkers et al., 2003; Marcks et al., 2011), while MSAD participants primarily suffered from secondary anxiety disorders.”
BackgroundResultInfluentialSelf-citationFeffer, K., Lee, H. H., Wu, W., Etkin, A., Demchenko, I., Cairo, T., Mazza, F., Fettes, P., Mansouri, F., Bhui, K. S., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.038 · Cited by 32
Lisoni, J., Barlati, S., Deste, G., Ceraso, A., Nibbio, G., Baldacci, G., & Vita, A. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110537 · Cited by 36
Examining challenging behaviors of clients with borderline personality disorder
Chalker, S. A., Carmel, A., Atkins, D. C., Landes, S. J., Kerbrat, A. H., & Comtois, K. A. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.10.003 · Cited by 29
Cost of borderline personality disorder in Catalonia (Spain)
Salvador‐Carulla, L., Bendeck, M., Ferrer, M., Andión, Ó., Aragonès, E., & Casas, M. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2014.07.001 · Cited by 38
“In a follow-up study, 40% of BPD patients were taking three or more drugs and about 10% were taking five or more [52].”
BackgroundPsychosocial functioning in adolescents with and without borderline personality disorder
Kramer, U., Temes, C. M., Magni, L. R., Fitzmaurice, G. M., Aguirre, B. A., Goodman, M. S., & Zanarini, M. C. (2017) · Personality and Mental Health · doi:10.1002/pmh.1377 · Cited by 34
Self-citationZimmerman, M. A., & Becker, L. (2022) · Psychological Medicine · doi:10.1017/s0033291722002197 · Cited by 41
Fatimah, H., Wiernik, B. M., Gorey, C. M., McGue, M. K., Iacono, W. G., & Bornovalova, M. A. (2019) · Psychological Medicine · doi:10.1017/s0033291719001260 · Cited by 30
“BPD is a major public health concern as it is associated with high distress, functional impairments, and utilization of mental health resources both cross-sectionally (Bender et al., 2001) and longitudinally (Zanarini et al., 2004; Bagge et al., 2005; Winograd et al., 2008).”
BackgroundLöffler‐Stastka, H., Blüml, V., & Boes, C. (2010) · Psychotherapy Research · doi:10.1080/10503300903436710 · Cited by 29
Borderline Personality Disorder
Emanuele, J. M., & Muehlenkamp, J. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1695-2_83 · Cited by 27
Personality traits and mental health treatment utilization
Hopwood, C. J., Quigley, B. D., Grilo, C. M., Sanislow, C. A., McGlashan, T. H., Yen, S., Shea, M. T., Zanarini, M. C., Gunderson, J. G., Skodol, A. E., et al. (2008) · Personality and Mental Health · doi:10.1002/pmh.51 · Cited by 32
Self-citationWhat's new in… Psychiatry: personality disorders
Tyrer, P. J. (2004) · Medicine · doi:10.1383/medc.32.7.1.66864 · Cited by 25
Chakhssi, F., Zoet, J. M., Oostendorp, J. M., Noordzij, M. L., & Sommers‐Spijkerman, M. (2019) · Journal of Personality Disorders · doi:10.1521/pedi_2019_33_439 · Cited by 30
Level of functioning in patients with borderline personality disorder. The Risskov-I study
Jørgensen, C. R., Kjølbye, M., Freund, C., Bøye, R., Jordet, H., & Andersen, D. (2009) · Nordic Psychology · doi:10.1027/1901-2276.61.1.42 · Cited by 32
“…in several areas, borderline personality disorder imposes significant burden on primary and secondary health care services (Rendu et al. 2002, Zanarini et al.2004) and has substantial societal costs in terms not only of individual suffering, suicide, somatic diseases etc. but also lost…”
BackgroundMedication for borderline personality disorder: A survey at a secure hospital
Haw, C., & Stubbs, J. H. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.590211 · Cited by 23
Carson-Wong, A. R., Hughes, C. D., & Rizvi, S. L. (2016) · Personality Disorders Theory Research and Treatment · doi:10.1037/per0000229 · Cited by 27
Romanowicz, M., Schak, K. M., Voort, J. L. V., Leung, J. G., Larrabee, B. R., & Palmer, B. A. (2019) · Journal of Personality Disorders · doi:10.1521/pedi_2019_33_405 · Cited by 21
The Process of Managing Medications in Patients with Borderline Personality Disorder
Silk, K. R. (2011) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000405361.88257.4a · Cited by 24
Self-citationTaylor, J. E., James, L. M., Reeves, M. D., & Kistner, J. A. (2008) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-008-9097-x · Cited by 23
The Effect of DBT Provision in Reducing the Cost of Adults Displaying the Symptoms of BPD
Amner, K. (2012) · British Journal of Psychotherapy · doi:10.1111/j.1752-0118.2012.01286.x · Cited by 19
Community mental healthcare for people with severe personality disorder: narrative review
Koekkoek, B., van Meijel, B., & Hutschemaekers, G. J. M. (2010) · The Psychiatrist · doi:10.1192/pb.bp.108.022426 · Cited by 23
Seizures and Altered Mental Status After Lamotrigine Overdose
Schwartz, M. D., & Geller, R. J. (2007) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31815bf239 · Cited by 19
The Use of Zonisamide for the Treatment of Psychiatric Disorders: A Systematic Review
Buoli, M., Grassi, S., Ciappolino, V., Serati, M., & Altamura, A. C. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000208 · Cited by 19
The mind-brain relation and neuroscientific foundations: II. Neurobehavioral integrations.
Meissner, W. (2006) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.2006.70.2.102 · Cited by 17
Medication utilization patterns and methods of suicidality in borderline personality disorder
Makela, E. H., Moeller, K. E., Fullen, J. E., & Gunel, E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1e479 · Cited by 18
Cailhol, L., Francois, M., Thalamas, C., Garrido, C., Birmes, P. J., Pourcel, L., Lapeyre‐Mestre, M., & Paris, J. (2016) · Personality and Mental Health · doi:10.1002/pmh.1350 · Cited by 25
Gyllenberg, D., & Sourander, A. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.644809 · Cited by 21
Brain Maturation in Conduct Disorder versus Borderline Personality Disorder
Ceballos, N. A., Houston, R. J., HESSELBROCK, V. M., & Bauer, L. O. (2006) · Neuropsychobiology · doi:10.1159/000092217 · Cited by 19
Burckell, L. A., & McMain, S. (2011) · Pragmatic Case Studies in Psychotherapy · doi:10.14713/pcsp.v7i2.1090 · Cited by 24
Pharmacological interventions for people with borderline personality disorder
Stoffers‐Winterling, J., Storebø, O. J., Vӧllm, B., Mattivi, J. T., Nielsen, S. S., Kielsholm, M. L., Faltinsen, E. G., Simonsen, E. H., & Lieb, K. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956 · Cited by 22
Borderline personality disorder—An overview for emergency clinicians
Koehne, K., & Sands, N. (2008) · Australasian Emergency Nursing Journal · doi:10.1016/j.aenj.2008.07.003 · Cited by 18
Zimmerman, M. A., Chelminski, I., Dalrymple, K. L., & Rosenstein, L. K. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900110 · Cited by 23
Borderline personality: a primary care context.
Sansone, R. A., & Sansone, L. A. (2004) · PubMed Central · Cited by 20
Crossing borders: theory, assessment and treatment in borderline personality disorder
Giesen-Bloo, J. H. (2006) · Research Publications (Maastricht University) · doi:10.26481/dis.20060908jg · Cited by 19
Hastrup, L. H., Jennum, P., Ibsen, R., Kjellberg, J., & Simonsen, E. H. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13292 · Cited by 15
Cailhol, L., Damsa, C., Bui, É., Klein, R., Adam, E., Schmitt, L., & Andreoli, A. (2008) · L Encéphale · doi:10.1016/j.encep.2007.04.004 · Cited by 18
Guillén, V., Tormo, M. E., Fonseca-Baeza, S., Botella, C., Baños, R., García‐Palacios, A., & Marco, J. H. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03312-0 · Cited by 26
Reasons for Change in Borderline Personality Disorder (and Other Axis II Disorders)
Zanarini, M. C. (2008) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.03.006 · Cited by 25
Self-citationPersonality traits in adults with hoarding disorder
Dozier, M. E., Davidson, E. J., Pittman, J. O. E., & Ayers, C. R. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.033 · Cited by 18
A meta-analysis on the neuropsychological correlates of Borderline Personality Disorder: An update
D’Iorio, A., Benedetto, G. L. D., & Santangelo, G. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105860 · Cited by 25
Waltz, J. A., Dimeff, L. A., Koerner, K., Linehan, M. M., Taylor, L. A., & Miller, C. J. (2009) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2008.08.004 · Cited by 17
Mayer, J. T., Nicolier, M., Gabriel, D., Masse, C., Giustiniani, J., Compagne, C., Vandel, P., Pazart, L., Haffen, É., & Bennabi, D. (2019) · Trials · doi:10.1186/s13063-019-3427-z · Cited by 21
Hersh, R. G. (2015) · Psychodynamic Psychiatry · doi:10.1521/pdps.2015.43.2.181 · Cited by 15
Cailhol, L., Thalamas, C., Garrido, C., Birmes, P. J., & Lapeyre‐Mestre, M. (2014) · L Encéphale · doi:10.1016/j.encep.2014.10.008 · Cited by 19
Riddle, M. C., Meeks, T., Alvarez, C. A., & Dubovsky, A. N. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2643 · Cited by 17
Cailhol, L., Pelletier, É., Rochette, L., Renaud, S., Koch, M., David, P., Villeneuve, É., Lunghi, C., & LESAGE, A. D. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000554 · Cited by 17
Sacco, F. C., Twemlow, S. W., & Fonagy, P. (2008) · Smith College Studies in Social Work · doi:10.1300/j497v77n04_03 · Cited by 18
“362 inpatients, Zanarini et al. (2004) found that a majority of BPD”
BackgroundMartinho, E., Fitzmaurice, G. M., Frankenburg, F. R., & Zanarini, M. C. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000132 · Cited by 15
“Good to excellent follow-up (within a generation of raters) and longitudinal (between generations of raters) interrater reliability were maintained throughout the course of the study for variables pertaining to treatment use.(16) Good to excellent follow-up and longitudinal interrater reliability were also maintained…”
BackgroundSelf-citationNelson, S. M., Huprich, S. K., Meehan, K. B., Siefert, C. J., Haggerty, G. D., Sexton, J. E., Dauphin, V. B., Macaluso, M., Zackula, R., Baade, L. E., et al. (2018) · Journal of Personality Assessment · doi:10.1080/00223891.2018.1492415 · Cited by 18
Neues zur Diagnostik und Therapie von Persönlichkeitsstörungen – Änderungen in ICD‑11
Jeung-Maarse, H., & Herpertz, S. C. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00936-7 · Cited by 16
Perplexing issues in personality disorders
Potter, N. N. (2004) · Current Opinion in Psychiatry · doi:10.1097/00001504-200411000-00011 · Cited by 13
Chang, T., Liu, S., Korslund, K., Lin, C., Lin, Y., Huang, H., Chen, S., Chang, Y., Sun, F., & Wu, S. (2022) · Asia-Pacific Psychiatry · doi:10.1111/appy.12451 · Cited by 12
“Borderline personality disorder (BPD) is a debilitating mental health disorder characterized by high rates of treatment dropout and which incurs expensive medical costs (Bender et al., 2001; Leichsenring et al., 2011; Zanarini et al., 2004).”
BackgroundVӧllm, B., Chadwick, K., Abdelrazek, T., & Smith, J. F. (2012) · Journal of Forensic Psychiatry and Psychology · doi:10.1080/14789949.2012.655764 · Cited by 15
“While no previous studies are available on psychotropic prescribing in forensic settings, those in community and inpatient general psychiatric settings have also found high prescribing levels ranging from 51% to 85% (Baker-Glenn et al., 2010; Garrett et al., 2011; Zanarini et al., 2004).”
BackgroundResultInfluentialSubgroups of Adolescent Girls With Borderline Personality Disorder Symptoms
Slavin‐Stewart, C., Boylan, K., & Burke, J. D. (2017) · Journal of Personality Disorders · doi:10.1521/pedi_2017_31_317 · Cited by 12
Personality Pathology in Primary Care: Ongoing Needs for Detection and Intervention
Huprich, S. K. (2018) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-017-9525-8 · Cited by 34
Risperidone for bipolar disorders
Sajatovic, M., Madhusoodanan, S., Fuller, M. A., Aulakh, L., & Keaton, D. B. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.2.177 · Cited by 12
García-Carmona, J. A., Simal-Aguado, J., Campos-Navarro, M. P., Valdivia-Muñoz, F., & Galindo‐Tovar, A. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000357 · Cited by 11
“Regarding atypical antipsychotics, clinical trials showed that olanzapine is effective in the management of anger and anxiety (Zanarini and Frankenburg, 2001; Bogenschutz and Nurnberg, 2004) and more effective compared with fluoxetine for relieving symptoms of depression and impulsive aggression (Zanarini et al., 2004…”
BackgroundFrancois, D., Roth, S. D., & Klingman, D. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150803-09 · Cited by 12
“Results from the RCTs should be examined with caution, as the data were limited by (1) the small size of the trials; (2) short duration (often lasting between 6 and 12 weeks); (3) high dropout rates; (4) inconsistent outcome measures; (5) enrollment bias (subjects were mostly women, and the heterogeneity of clinical f…”
Kline, E. A., Lekkas, D., Bryan, A. C., Nemesure, M. D., Griffin, T. Z., Collins, A. C., Price, G. D., Heinz, M. V., Nepal, S. K., Pillai, A., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.104 · Cited by 10
Mansour, M. E. M., Alsaadany, K. R., Ahmed, M. S., Elmetwalli, A. E., & Serag, I. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00561-1 · Cited by 10
“From a therapeutic perspective, although no specific pharmacological treatment has been licensed, about 75% of BPD patients regularly take psychotropic medication [23, 24].”
Cailhol, L., Riedi, G., Mathur, A., Czapla, P., Charpentier, S., Genestal, M., & Birmes, P. J. (2014) · L Encéphale · doi:10.1016/j.encep.2013.09.003 · Cited by 9
Carmel, A., Comtois, K. A., Harned, M. S., Holler, R., & McFarr, L. M. (2015) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2015.04.001 · Cited by 12
Cailhol, L., Bouchard, S., Belkadi, A., Benkirane, G., Corduan, G., Dupouy, S., Villeneuve, É., & Guelfi, J. (2010) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2009.06.020 · Cited by 12
Shah, R., Temes, C. M., Frankenburg, F. R., Fitzmaurice, G. M., & Zanarini, M. C. (2020) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2020.1719259 · Cited by 10
“Four semistructured interviews were administered by a masters-level interviewer who was blind to the patient’s clinical diagnoses: (1) Background Information Schedule (BIS) (Zanarini, Frankenburg, Hennen, Reich, & Silk, 2005; Zanarini, Frankenburg, Hennen, & Silk, 2004; Zanarini, Frankenburg, Reich, & Fitzmaurice, 201…”
MethodSelf-citationBuoli, M., GATTONI, E., Collantoni, E., Monteleone, A. M., Solmi, M., Longo, L., Ribolsi, M., Santambrogio, J., Bersani, F. S., Aguglia, A., et al. (2020) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2020.1865405 · Cited by 9
Psychopathological Determinants of Quality of Life in People with Borderline Personality Disorder
Stefanatou, P., Xenaki, L., Konstantakopoulos, G., Papaiakovou, A., Ralli, I., Berk, A. D., Katopodi, D. S., Pantagoutsou, A., Charitaki, A., Ginieri-Coccossis, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010030 · Cited by 10
Second-generation antipsychotic use in borderline personality disorder: What are we targeting?
Wasylyshen, A., & WILLIAMS, A. M. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.03.82 · Cited by 9
“83 (5-20) Anxiety, depression, impulsivity/ aggressive behavior Linehan et al,(24) 2008 DBPC; 31 24 4.”
Borderline personality disorder - a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C. G., Falkai, P., & Wedekind, D. (2011) · European Psychiatry · doi:10.1016/s0924-9338(11)72713-4 · Cited by 8
Broadbear, J. H., Nesci, J. B., Thomas, R. A., Thompson, K. N., Beatson, J. A., & Rao, S. (2016) · Australasian Psychiatry · doi:10.1177/1039856216654391 · Cited by 9
Juanmartí, F. B., CIDIE, U. R. L., Lizeretti, N. P., & CIDIE, U. R. L. (2017) · Papeles del Psicólogo - Psychologist Papers · doi:10.23923/pap.psicol2017.2832 · Cited by 23
Kramer, U., Temes, C. M., Frankenburg, F. R., Glass, I. V., & Zanarini, M. C. (2023) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-023-00236-x · Cited by 7
Self-citationTomasetti, C., Autullo, G., Ballerini, A. C., de Bartolomeis, A., Dell’Osso, B. M., Fiorentini, A., Tonioni, F., Villari, V., & Berardis, D. D. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00507-z · Cited by 8
Calvo, N., Valero, S., Arntz, A. R., Andión, Ó., Matalí, J. L., Navascues, V., Ramos‐Quiroga, J. A., Casas, M., & Ferrer, M. (2017) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2017.08.003 · Cited by 9
Bouchard, S. (2011) · Santé mentale au Québec · doi:10.7202/1000554ar · Cited by 15
“…tendance à chercher de l’aide dans les services de santé mentale ; près de 95 % des patients avec un TPL ont tenté de profiter d’une psychothérapie individuelle, 72 % ont déjà été hospitalisés et près de 70 % ont une prescription pour trois médications psychotropes ou plus (Zanarini et al., 2004).”
Depressive Disorders in Borderline Personality Disorder: Phenomenology and Biological Markers
Goodman, M. S., Chowdhury, S., New, A. S., & Siever, L. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1314-5_2 · Cited by 8
“However, there appear to be a core subset of BPD symptoms, especially in the affective and interpersonal realms, that persist even after the more dramatic, impulsive, or demanding behaviors have subsided [ 36 ], as well as a subset of BPD patients who fail to remit and continue to show poor judgment and high treatment…”
BackgroundKaran, E., Niesten, I. J. M., Frankenburg, F. R., Fitzmaurice, G. M., & Zanarini, M. C. (2016) · Personality and Mental Health · doi:10.1002/pmh.1327 · Cited by 9
Self-citationLivesley, W. J. (2017) · Cambridge University Press eBooks · doi:10.1017/9781107298613 · Cited by 36
Bridging the Gap Between Remission and Recovery in BPD: Qualitative Versus Quantitative Perspectives
Soloff, P. H. (2019) · Journal of Personality Disorders · doi:10.1521/pedi_2019_33_419 · Cited by 14
Book review: Handbook of drug administration via enteral feeding tubes
Snowden, L. (2016) · Australian Prescriber · doi:10.18773/austprescr.2016.004 · Cited by 8
Psychoeducation for borderline personality difficulties: a preliminary study
Rocca, F., Finamore, C., Stamp, S., Kuhn-Thompson, F., & Dale, O. (2021) · Mental Health Review Journal · doi:10.1108/mhrj-04-2020-0023 · Cited by 7
Borderline-Persönlichkeitsstörung: Veränderung der Hirnstruktur und -funktion durch Psychotherapie
Schmahl, C. G., Niedtfeld, I., & Herpertz, S. C. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0587-0 · Cited by 7
Indication différentielle des psychothérapies adaptées au trouble de la personnalité limite
Cailhol, L., Bui, É., Rouillon, L., Bruno, N., Lemoalle, A., Faure, K., Klein, R., Lamy, P., Guelfi, J., & Schmitt, L. (2010) · L Encéphale · doi:10.1016/j.encep.2010.04.002 · Cited by 8
Efficacy and Safety of Lamotrigine for Adults with Bipolar Disorder in a Private Practice Setting
Ginsberg, L. (2006) · CNS Spectrums · doi:10.1017/s1092852900014504 · Cited by 5
Roininen, S. M., Cheetham, M., Mueller, B. U., & Battegay, E. J. (2019) · Medicine · doi:10.1097/md.0000000000017101 · Cited by 8
Borderline Personality Disorder
Chapman, A. L., Hope, N. H., & Turner, B. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108333931.041 · Cited by 10
Wöckel, L., Goth, K., Matic, N., Zepf, F. D., Holtmann, M. H., & Poustka, F. (2009) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.a000005 · Cited by 6
Black, D. W., Allen, J., McCormick, B. A., & Blum, N. S. (2011) · Personality and Mental Health · doi:10.1002/pmh.167 · Cited by 6
Neuropeptide Y receptors as therapeutic targets in anxiety and depression
Sajdyk, T. J. (2005) · Drug Development Research · doi:10.1002/ddr.20031 · Cited by 7
Tepper, D., Sellar, B., Shipley, S., Smith, R. A., & Murray, C. M. (2025) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674251393159 · Cited by 5
“Persistent challenges in functional recovery manifest as disability benefits (Kramer et al., 2023) and prolonged psychotherapy (Zanarini et al., 2004).”
Lisoni, J., Baldacci, G., Nibbio, G., Baglioni, A., Bortoletti, D., Bezzi, F., Cremonesi, A., Manera, B., Ardesi, M., Roncali, D., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.121050 · Cited by 6
Hafkemeijer, L., Slotema, K., de Haard, N., & de Jongh, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1283145 · Cited by 7
Rational drug treatment for personality disorders
Tyrer, P. J., & Newton‐Howes, G. (2005) · Psychiatry · doi:10.1383/psyt.4.3.11.62449 · Cited by 5
Recommending Interventions for a Borderline Personality Disorder Patient
Choudhary, S., & Thapa, K. (2013) · Psychological Studies · doi:10.1007/s12646-013-0181-2 · Cited by 5
A Psychodynamic Approach for the General Psychiatrist
Hersh, R. G. (2018) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2018.01.006 · Cited by 6
“Despite this, patients with BPD, for example, are unusually high users of all subtypes of psychiatric medication.(23) Risk management education tends to be generic and does not routinely address the particular complications associated with prescribing medication to patients with PD symptoms, particularly those with su…”
BackgroundZimmerman, M., McGonigal, P. T., Moon, S. S., Mehring, L. B., LaHaye, J., Berges, A., & Schmidhofer, S. (2018) · Annals of Clinical Psychiatry · doi:10.1177/104012371803000310 · Cited by 7
Metadata
- Authors
- Zanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R.
- Affiliations
- Harvard University (US)
- ORCID
- Zanarini, Mary C.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2004-01-15
- Volume
- 65
- Issue
- 1
- Pages
- 28-36
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2993584274
- Cited by
- 285
- References
- 0
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 11 · 2021: 14 · 2020: 11 · 2019: 18 · 2018: 21 · 2017: 9 · 2016: 16 · 2015: 10 · 2014: 16 · 2013: 12 · 2012: 17
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-62169, R29MH047588, R01MH062169, MH-47588)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- borderline personality disorder, mental health service utilization, psychiatric hospitalization, outpatient psychotherapy, polypharmacy, psychotropic drugs, Axis II personality disorders, long-term follow-up, treatment continuity
- MeSH terms
- Adolescent, Adult, Borderline Personality Disorder, Drug Therapy, Female, Hospitalization, Humans, Inpatients, Male, Mental Health Services, Outpatients, Prospective Studies, Psychotherapy, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.